non-linear curve fit tool included in origin 5.0 software Search Results


nonlinear regression origin 9.1  (OriginLab corp)
90
OriginLab corp nonlinear regression origin 9.1
Nonlinear Regression Origin 9.1, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc04599451-146-22-39?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
nonlinear regression origin 9.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
tablecurve 2d v5 01  (SYSTAT)
95
SYSTAT tablecurve 2d v5 01
Tablecurve 2d V5 01, supplied by SYSTAT, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/10__1155_slash_2015_slash_841213-79-13-16?v=SYSTAT
Average 95 stars, based on 1 article reviews
tablecurve 2d v5 01 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
electromyography (emg) research  (MyoLearn)
99
MyoLearn electromyography (emg) research
Electromyography (Emg) Research, supplied by MyoLearn, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/custom%40emg%4035817814?v=MyoLearn
Average 99 stars, based on 1 article reviews
electromyography (emg) research - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
ti sapphire femtosecond laser  (Coherent Corp)
94
Coherent Corp ti sapphire femtosecond laser
Ti Sapphire Femtosecond Laser, supplied by Coherent Corp, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc11464912-202-6-10?v=Coherent+Corp
Average 94 stars, based on 1 article reviews
ti sapphire femtosecond laser - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
ultrasound contrast agent micromarker  (FUJIFILM VisualSonics Inc)
90
FUJIFILM VisualSonics Inc ultrasound contrast agent micromarker
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Ultrasound Contrast Agent Micromarker, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc05665074-251-16-21?v=FUJIFILM+VisualSonics+Inc
Average 90 stars, based on 1 article reviews
ultrasound contrast agent micromarker - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
functionf x  (SYSTAT)
99
SYSTAT functionf x
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Functionf X, supplied by SYSTAT, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pm34496214-53-19-54?v=SYSTAT
Average 99 stars, based on 1 article reviews
functionf x - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
ipg readystrip  (Bio-Rad)
96
Bio-Rad ipg readystrip
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Ipg Readystrip, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc03108835-399-8-16?v=Bio-Rad
Average 96 stars, based on 1 article reviews
ipg readystrip - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
quest graphtm ic 50 calculator  (AAT Bioquest)
90
AAT Bioquest quest graphtm ic 50 calculator
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Quest Graphtm Ic 50 Calculator, supplied by AAT Bioquest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc09697001-354-9-18?v=AAT+Bioquest
Average 90 stars, based on 1 article reviews
quest graphtm ic 50 calculator - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hsp104 peptide fragments  (Thermo Fisher)
99
Thermo Fisher hsp104 peptide fragments
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Hsp104 Peptide Fragments, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/10__1074_slash_jbc__m113__520759-132-17-100?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
hsp104 peptide fragments - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
p10ez  (Becton Dickinson)
90
Becton Dickinson p10ez
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
P10ez, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pm33325335-42-24-26?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
p10ez - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
grafit workspace  (ERITHACUS SOFTWARE LIMITED)
90
ERITHACUS SOFTWARE LIMITED grafit workspace
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Grafit Workspace, supplied by ERITHACUS SOFTWARE LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc04068450-100-13-15?v=ERITHACUS+SOFTWARE+LIMITED
Average 90 stars, based on 1 article reviews
grafit workspace - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nonlinear curve fitting software pharm/pcs version 4.2  (Verlag GmbH)
90
Verlag GmbH nonlinear curve fitting software pharm/pcs version 4.2
Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast <t>ultrasound:</t> from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.
Nonlinear Curve Fitting Software Pharm/Pcs Version 4.2, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+curve+fit+tool+included+in+origin+5%2E0+software/pmc02834341-64-15-22?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
nonlinear curve fitting software pharm/pcs version 4.2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast ultrasound: from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.

Journal: Oncoimmunology

Article Title: The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression

doi: 10.1080/2162402X.2017.1346765

Figure Lengend Snippet: Anti-tumoral DMXAA effects begin with vascular damages and early cell death in transplanted PyMT tumors. A. Follow-up of transplanted PyMT tumor controls (left) and after one i.p. injection of DMXAA (23 mg/kg) (center). The right panel gives the relative tumor size changes after day 0, the day of treatment: [(size at day X)-(size at day 0)]/ (size at day 0). n = 20 tumors for each condition. The average curves are shown in color. B. Assessment of tumor perfusion using contrast ultrasound: from left to right: 1) acquisition in the largest diameter showing tumor anatomy; 2) baseline image in non-linear imaging mode before contrast enhancement of non-treated tumor; 3) Peak Enhancement (PE) image obtained after bolus injection of Ultrasound Contrast Agent (UCA) in the non-treated tumor; 4) UCA-PE image 6 hours after DMXAA injection; 5) UCA-PE image 7 d after DMXAA injection. Contrast enhancement observed in images after i.v. UCA injection illustrate that DMXAA treatment is associated with a strong alteration of vessel functionality as revealed by the absence of micro-bubbles circulation 6 h after DMXAA. Slight recovery of perfusion is observable at the tumor periphery after 7 d. C. DAPI staining shows an early DMXAA-induced cell death (DAPI + cells) in both tumor and endothelial cells. D. Quantification of relative DAPI + areas at different time points after DMXAA injection. Each point is a 20x image field, from n = 2 independent experiments. *** = p < 0.001 (t-test). E. As judged from CD31 + staining, 24 h after its i.p. injection, DMXAA has induced major vascular damages in the center of the tumor. The edge of the tumors is indicated with yellow lines. F. Ly6G + neutrophils are much more abundant one day after DMXAA than in control conditions.

Article Snippet: Then acquisition of a 2D image sequence in nonlinear mode was triggered, and 50 μl of ultrasound contrast agent suspension (Micromarker, Visualsonics) containing 5.10 9 microbubbles was injected through the venous catheter, and 90s video loops showing contrast enhancement were stored.

Techniques: Injection, Imaging, Staining, Control